Total Brain (ASX:TTBO) ROCE %: -62.83% (As of Dec. 2022)


What is Total Brain ROCE %?

Total Brain ASX:TTBO ROCE % is -62.83% as of Dec. 2022. The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Total Brain's annualized ROCE % for the quarter that ended in Dec. 2022 was -62.83%.

Total Brain  (ASX:TTBO) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Total Brain ROCE % Related Terms

Total Brain ROCE % Historical Data

* Premium members only.

The historical data trend for Total Brain's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Brain ROCE % Chart

Total Brain Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -102.49 -40.61 -32.76 -37.70 -100.68

Total Brain Semi-Annual Data
Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.96 -42.77 -24.90 -146.17 -62.83

Total Brain ROCE % Calculation

Total Brain's annualized ROCE % for the fiscal year that ended in Jun. 2022 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2022 )  (A: Jun. 2021 )(A: Jun. 2022 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2022 )  (A: Jun. 2021 )(A: Jun. 2022 )
=-14.213/( ( (24.088 - 6.106) + (14.692 - 4.44) )/ 2 )
=-14.213/( (17.982+10.252)/ 2 )
=-14.213/14.117
=-100.68 %

Total Brain's ROCE % of for the quarter that ended in Dec. 2022 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2022 )  (Q: Jun. 2022 )(Q: Dec. 2022 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2022 )  (Q: Jun. 2022 )(Q: Dec. 2022 )
=-5.356/( ( (14.692 - 4.44) + (7.274 - 0.477) )/ 2 )
=-5.356/( ( 10.252 + 6.797 )/ 2 )
=-5.356/8.5245
=-62.83 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2022) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -62.83% mean?
Total Brain (ASX:TTBO) has a ROCE % of -62.83% as of Dec. 2022.
Is Total Brain's ROCE % too high?
Total Brain's current ROCE % is -62.83%.
How does Total Brain's ROCE % compare to PEARQ and BBLNF?
Total Brain's ROCE % of -62.83% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Total Brain's current ROCE % is -62.83%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Total Brain stock overvalued right now?
Total Brain (ASX:TTBO) has a current ROCE % of -62.83%. The current ROCE % is -62.83%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Total Brain (ASX:TTBO), the current ROCE % is -62.83% as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Total Brain Business Description

Address 15 Belvoir Street, Surry Hills, NSW, AUS, 2010
Total Brain Ltd offers brain performance management platform. The company has build and validate digital tools to access, monitor, screen, and train the brain at the capacity makers level. It operates through one segment namely, development and commercialisation of brain health products.